Literature DB >> 31319989

CT screening for lung cancer: Are we ready to implement in Europe?

Haval Balata1, Matthew Evison2, Anna Sharman2, Philip Crosbie3, Richard Booton2.   

Abstract

Lung cancer screening with low-dose CT (LDCT) is already available in certain parts of the world, such as the United States, but not yet in Europe. The recently published European position statement on lung cancer screening has recommended planning for implementation of screening to start within 18-months [1]. Pilot European programmes are already underway, primarily in the United Kingdom (UK), delivering lung cancer screening to their local populations. This review article acknowledges the evidence base for LDCT screening and will discuss the challenges that still need to be overcome in an attempt to answer the question: are we ready to implement in Europe?
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Early detection; Low-dose CT (LDCT); Lung cancer; Lung cancer screening

Mesh：

Year:  2019        PMID： 31319989     DOI： 10.1016/j.lungcan.2019.05.028

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


  6 in total

1.  Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital database.

Authors:  Marta Soares; Luís Antunes; Patrícia Redondo; Marina Borges; Ruben Hermans; Dony Patel; Fiona Grimson; Robin Munro; Carlos Chaib; Laure Lacoin; Melinda Daumont; John R Penrod; John C O'Donnell; Maria José Bento; Francisco Rocha Gonçalves
Journal:  Lung Cancer Manag       Date:  2021-02-19

2.  Development of a machine learning-based multimode diagnosis system for lung cancer.

Authors:  Shuyin Duan; Huimin Cao; Hong Liu; Lijun Miao; Jing Wang; Xiaolei Zhou; Wei Wang; Pingzhao Hu; Lingbo Qu; Yongjun Wu
Journal:  Aging (Albany NY)       Date:  2020-05-23       Impact factor: 5.682

3.  Motivation is not enough: A qualitative study of lung cancer screening uptake in Australia to inform future implementation.

Authors:  Kate L A Dunlop; Henry M Marshall; Emily Stone; Ashleigh R Sharman; Rachael H Dodd; Joel J Rhee; Sue McCullough; Nicole M Rankin
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

4.  Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.

Authors:  Vera Constâncio; Sandra P Nunes; Catarina Moreira-Barbosa; Rui Freitas; Jorge Oliveira; Inês Pousa; Júlio Oliveira; Marta Soares; Carlos Gonçalves Dias; Teresa Dias; Luís Antunes; Rui Henrique; Carmen Jerónimo
Journal:  Clin Epigenetics       Date:  2019-12-02       Impact factor: 6.551

5.  Artificial neural networks improve LDCT lung cancer screening: a comparative validation study.

Authors:  Yin-Chen Hsu; Yuan-Hsiung Tsai; Hsu-Huei Weng; Li-Sheng Hsu; Ying-Huang Tsai; Yu-Ching Lin; Ming-Szu Hung; Yu-Hung Fang; Chien-Wei Chen
Journal:  BMC Cancer       Date:  2020-10-22       Impact factor: 4.430

6.  Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.

Authors:  Frank M Sullivan; Frances S Mair; William Anderson; Pauline Armory; Andrew Briggs; Cindy Chew; Alistair Dorward; John Haughney; Fiona Hogarth; Denise Kendrick; Roberta Littleford; Alex McConnachie; Colin McCowan; Nicola McMeekin; Manish Patel; Petra Rauchhaus; Lewis Ritchie; Chris Robertson; John Robertson; Jose Robles-Zurita; Joseph Sarvesvaran; Herbert Sewell; Michael Sproule; Thomas Taylor; Agnes Tello; Shaun Treweek; Kavita Vedhara; Stuart Schembri
Journal:  Eur Respir J       Date:  2021-01-14       Impact factor: 16.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.